| Two-peptide bacteriocins produced by lactic acid bacteria S Garneau, NI Martin, JC Vederas Biochimie 84 (5-6), 577-592, 2002 | 411 | 2002 |
| Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity NI Martin, T Sprules, MR Carpenter, PD Cotter, C Hill, RP Ross, ... Biochemistry 43 (11), 3049-3056, 2004 | 223 | 2004 |
| Isolation, Structural Characterization, and Properties of Mattacin (Polymyxin M), a Cyclic Peptide Antibiotic Produced byPaenibacillus kobensis M NI Martin, H Hu, MM Moake, JJ Churey, R Whittal, RW Worobo, ... Journal of Biological Chemistry 278 (15), 13124-13132, 2003 | 153 | 2003 |
| Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases FJ Dekker, T van den Bosch, NI Martin Drug discovery today 19 (5), 654-660, 2014 | 145 | 2014 |
| β-lactam/β-lactamase inhibitor combinations: an update KHME Tehrani, NI Martin Medchemcomm 9 (9), 1439-1456, 2018 | 129 | 2018 |
| Multidrug-resistant enterococcal infections: new compounds, novel antimicrobial therapies? RM van Harten, RJL Willems, NI Martin, APA Hendrickx Trends in microbiology 25 (6), 467-479, 2017 | 127 | 2017 |
| The expanding role of lipid II as a target for lantibiotics NI Martin, E Breukink Future Medicine Ltd 2 (5), 513-525, 2007 | 91 | 2007 |
| Specificity of the transport of lipid II by FtsW in Escherichia coli T Mohammadi, R Sijbrandi, M Lutters, J Verheul, NI Martin, ... Journal of biological chemistry 289 (21), 14707-14718, 2014 | 86 | 2014 |
| Hit'em where it hurts: The growing and structurally diverse family of peptides that target lipid-II SF Oppedijk, NI Martin, E Breukink Biochimica Et Biophysica Acta (BBA)-Biomembranes 1858 (5), 947-957, 2016 | 83 | 2016 |
| An Escherichia coli expression–based method for heme substitution JJ Woodward, NI Martin, MA Marletta Nature Methods 4 (1), 43-45, 2007 | 82 | 2007 |
| Multiple on-resin olefin metathesis to form ring-expanded analogues of the lantibiotic peptide, lacticin 3147 A2 VR Pattabiraman, JL Stymiest, DJ Derksen, NI Martin, JC Vederas Organic Letters 9 (4), 699-702, 2007 | 81 | 2007 |
| Complement-dependent outer membrane perturbation sensitizes Gram-negative bacteria to Gram-positive specific antibiotics DAC Heesterbeek, NI Martin, A Velthuizen, M Duijst, M Ruyken, ... Scientific Reports 9 (1), 3074, 2019 | 73 | 2019 |
| The second step of the nitric oxide synthase reaction: evidence for ferric-peroxo as the active oxidant JJ Woodward, MM Chang, NI Martin, MA Marletta Journal of the American Chemical Society 131 (1), 297-305, 2009 | 72 | 2009 |
| Semisynthetic lipopeptides derived from nisin display antibacterial activity and lipid II binding on par with that of the parent compound T Koopmans, TM Wood, P ’t Hart, LHJ Kleijn, APA Hendrickx, RJL Willems, ... Journal of the american chemical society 137 (29), 9382-9389, 2015 | 66 | 2015 |
| A Rapid and Efficient Assay for the Characterization of Substrates and Inhibitors of Nicotinamide N-Methyltransferase MJ van Haren, J Sastre Torano, D Sartini, M Emanuelli, RB Parsons, ... Biochemistry 55 (37), 5307-5315, 2016 | 62 | 2016 |
| Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT) with Enhanced Activity Y Gao, MJ Van Haren, EE Moret, JJM Rood, D Sartini, A Salvucci, ... Journal of medicinal chemistry 62 (14), 6597-6614, 2019 | 59 | 2019 |
| Liposome functionalization with copper-free “click chemistry” EO Blenke, G Klaasse, H Merten, A Plückthun, E Mastrobattista, NI Martin Journal of Controlled Release 202, 14-20, 2015 | 58 | 2015 |
| Probing the Interaction of Aspergillomarasmine A with Metallo-β-lactamases NDM-1, VIM-2, and IMP-7 A Bergstrom, A Katko, Z Adkins, J Hill, Z Cheng, M Burnett, H Yang, ... ACS infectious diseases 4 (2), 135-145, 2018 | 55 | 2018 |
| NG-Hydroxyguanidines from Primary Amines NI Martin, JJ Woodward, MA Marletta Organic Letters 8 (18), 4035-4038, 2006 | 55 | 2006 |
| Thiol-containing metallo-β-lactamase inhibitors resensitize resistant Gram-negative bacteria to meropenem KHME Tehrani, NI Martin ACS Infectious Diseases 3 (10), 711-717, 2017 | 53 | 2017 |
